Catalyst Wire Dossier Catalyst Wire Dossier

Coversin

rVA576 · AKARI Therapeutics
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Coversin, covering 2023-07-12 to 2025-05-04. Get the full timeline:

Most recent: Clinical Trial Update: Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms [Phase 2]

See pricing